TheySaid
Tags
Pricing model
Upvote
0
TheySaid is an AI-driven platform for surveys and feedback, revolutionizing traditional questionnaires into interactive, conversational experiences. By leveraging artificial intelligence, it formulates tailored questions, facilitates interviews, and evaluates responses to offer actionable insights for diverse feedback types. Companies and professionals may utilize TheySaid to obtain more profound customer insights, boost response rates, streamline survey design and analysis, and effortlessly incorporate feedback collection into current workflows, thereby improving decision-making with AI-enhanced data interpretation.
Similar neural networks:
0
Kino AI is an AI tool designed to manage footage metadata and organize media resources. It offers numerous functionalities, including inferred metadata, keyword indexing, easy browsing of footage, backup, synchronization, organization, AI-driven transcription, metadata tagging, and more. By automating repetitive and critical workflow tasks, Kino AI aims to streamline the editing process. A private beta will be available shortly, and interested users are encouraged to join the waitlist for early access.
0
Convo is a platform driven by AI for carrying out qualitative user research via automated interviews and surveys. It facilitates natural voice dialogues and accommodates various languages, enabling researchers to acquire comprehensive insights on a large scale. The tool instantly analyzes responses, offering value to product managers, UX designers, and market researchers requiring prompt, real-time feedback from users to guide decision-making and enhance product experiences.
PercepticOS is a collaborative research platform that enables R&D teams and AI to work together on joint studies in a single integrated environment. The system is built to ensure that all decisions are traceable and verifiable, providing organizations with complete control over their research results. The platform seems to be oriented towards synthesizing scientific and clinical evidence, facilitating the structured analysis of complex subjects like biomedical research. Access to the platform is currently available only by application, indicating that it is in an early stage of availability or has an invite-only policy.